Daniel Janse

Daniel Janse

Director Ejecutivo en
Affyimmune Therapeutics, Inc.
.
Health Technology
Consumer Services
Commercial Services

Perfil

Daniel Janse is currently the President & Chief Executive Officer at Affyimmune Therapeutics, Inc. He previously held positions as the Director at Cell Therapy Ltd. in 2011, Senior Director at Juno Therapeutics GmbH from 2016 to 2018, Managing Director at Northpond Ventures LLC in 2023, Senior Director at Johnson & Johnson Innovation from 2013 to 2016, Manager at McKinsey & Co., Inc. from 2008 to 2011, Investment Manager at Inventages Venture Capital Investment, Inc. from 2011 to 2013, and Chief Operating Officer at Arbor Biotechnologies, Inc. from 2020 to 2021.
Dr. Janse obtained his undergraduate degree from Brown University in 1998 and his doctorate degree from Harvard University in 2005.

Cargos activos de Daniel Janse

EmpresasCargoInicio
Director Ejecutivo 15/07/2024

Antiguos cargos conocidos de Daniel Janse.

EmpresasCargoFin
Director/Miembro de la Junta 01/01/2023
Director de Operaciones 31/05/2021
Inversor de Capital Privado 31/07/2018
Inversor de Capital Privado 30/09/2016
Corporate Officer/Principal 31/07/2013
Ver el detalle de la experiencia de Daniel Janse.

Formación de Daniel Janse.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

95

Relaciones de 1er grado

10

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas10

Consumer Services

Commercial Services

Consumer Services

Finance

Health Technology

Health Services

Health Technology

Health Technology

Finance

Commercial Services